Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01413646 · ClinicalTrials.gov registry record · NA
Effects of Walnuts on Endothelial Function in Overweight Adults With at Least One Factor of Metabolic Syndrome
A NA study, sponsored by Griffin Hospital.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT01413646 is a NA study that has completed, run by Griffin Hospital. The registered enrollment target is 40 participants.
The verdict
NCT01413646, a NA study, has completed, sponsored by Griffin Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the effects of walnut consumption on endothelial function and lipid markers in overweight patients with at least one factor of metabolic syndrome as compared to the control group.
Interventions
- DIETARY_SUPPLEMENT Walnut Supplementation
- DIETARY_SUPPLEMENT No walnut supplementation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2010-02 |
| Est. Completion | 2010-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01413646
The ClinicalTrials.gov registry entry for NCT01413646 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Griffin Hospital, which has 22 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Walnut Supplementation is the first listed.
NCT01413646 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01413646 about?
NCT01413646 is a clinical study titled "Effects of Walnuts on Endothelial Function in Overweight Adults With at Least One Factor of Metabolic Syndrome". The purpose of this study is to examine the effects of walnut consumption on endothelial function and lipid markers in overweight patients with at least one factor of metabolic syndrome as compared to the control group.
What is the current status of trial NCT01413646?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2010-02. Estimated completion is 2010-12.
What interventions are being tested in trial NCT01413646?
The interventions under investigation include: Walnut Supplementation (DIETARY_SUPPLEMENT), No walnut supplementation (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01413646?
This trial is sponsored by Griffin Hospital, which has 22 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.